Clinical Trials Logo

Bipolar Depression clinical trials

View clinical trials related to Bipolar Depression.

Filter by:

NCT ID: NCT00305578 Completed - Bipolar Depression Clinical Trials

Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression

Start date: August 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate whether addition of memantine to bipolar depression patients who have had an incomplete response to lamotrigine (Lamictal) which is frequently used to treat bipolar depression in the clinical setting. At present, memantine is approved for use in the treatment of Alzheimer's disease or dementia, but not for use for the treatment of bipolar depression. Subjects will be asked to participate because they are suffering from bipolar depression associated and have had an inadequate response to lamotrigine. Subjects will have to be on at least 100 mg per day, for at least 4 weeks.

NCT ID: NCT00224510 Completed - Bipolar Disorder Clinical Trials

A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium

Start date: August 2002
Phase: Phase 3
Study type: Interventional

This is a study that, in the first 16 weeks, investigates whether lamotrigine versus placebo offers effect on depressive episodes for patients with bipolar disorder (also known as manic depressive disorder) who use lithium. In the following 50 weeks it is investigated whether these patients experience effect on their depressive and/ or (hypo)manic episodes.

NCT ID: NCT00217165 Completed - Bipolar Disorder Clinical Trials

Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study

Start date: April 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether the amino acid taurine has effects on mood stability in bipolar disorder.

NCT ID: NCT00206141 Completed - Depression Clinical Trials

Seroquel in Bipolar Depression Versus Lithium

Start date: August 2005
Phase: Phase 3
Study type: Interventional

This study is being carried out to see if quetiapine fumarate (Seroquel) is effective in treating bipolar depression during an 8-week acute phase compared with placebo and lithium, followed by continuation treatment for 26 up to 52 with quetiapine fumarate (Seroquel) compared to placebo.

NCT ID: NCT00203567 Completed - Bipolar Depression Clinical Trials

Carbamazepine Extended-Release for the Treatment of Bipolar Depression

Start date: August 2005
Phase: Phase 4
Study type: Interventional

To study the efficacy and safety of beaded extended-release Carbamazepine (Equetro) in the treatment of patients with Bipolar Disorder with a Major Depressive Episode.

NCT ID: NCT00203528 Completed - Substance Abuse Clinical Trials

Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder

Start date: January 2004
Phase: Phase 4
Study type: Interventional

The primary objective is to evaluate the safety and efficacy of divalproex extended release (ER) compared to risperidone in the treatment of bipolar disorder with comorbid substance use disorder

NCT ID: NCT00198198 Completed - Bipolar Depression Clinical Trials

Aripiprazole Treatment of Bipolar Depression

Start date: August 2005
Phase: Phase 4
Study type: Interventional

This is a study of addition of aripirazole to the treatment of bipolar depressed patients who are not better on the medications that they are currently receiving.

NCT ID: NCT00119652 Completed - Depression Clinical Trials

Seroquel in Bipolar Depression Versus SSRI

EMBOLDEN II
Start date: May 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether quetiapine is effective and safe in the acute treatment of bipolar depression and whether the effect is maintained when treatment is continued.